Composition to treat and/or prevent gastrointestinal infection
The invention relates to a composition for the treatment and/or prevention of infection by gastrointestinal pathogens, in particular Helicobacter pylori and/or a disease associated with infection by said gastrointestinal pathogen in mammals.
1. A method for the treatment of infection by gastrointestinal pathogens in mammals which comprises administering to a patient in need thereof an effective amount of a composition comprising pea protein hydrolysate, wherein the gastrointestinal pathogen is Helicobacter pylori ( H. pylori ).
2. The method of claim 1 , wherein the composition comprises a lipid, a protein and a carbohydrate constituent wherein:
the lipid constituent provides 5 to 50% of the total calories;
the protein constituent provides 5 to 50% of the total calories;
the carbohydrate constituent provides 15 to 90% of the total calories; and
the protein constituent comprises: (i) pea protein hydrolysate, and (ii) at least one nitrogen source selected from the group consisting of milk proteins, milk protein hydrolysate, egg proteins, egg protein hydrolysate and mixtures thereof.
3. The method of claim 2 , wherein the nitrogen source is selected from the group consisting of:
(i) a nitrogen source comprising at least one milk protein selected from the group consisting of non-hydrolysed cows whey and non-hydrolysed cows casein,
(ii) a nitrogen source comprising at least one milk protein hydrolysate selected from the group consisting of hydrolysed cows whey and hydrolysed cows casein, and
(iii) any combination thereof.
4. The method of claim 2 , wherein the carbohydrate constituent comprises a soluble, non-digestible, fermentable oligosaccharide.
5. The method of claim 1 , wherein the osmolality of the composition is between 50 and 500 mOsm/kg.
6. The method of claim 1 , wherein the composition is in the form of a nutritional or pharmaceutical composition.